Genocea Biosciences Inc (GNCA)

Add to Watchlists
Create an Alert
3.42 -0.16  -4.47% NASDAQ Sep 19, 16:59 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
11/01/2019 09:00 EDT Misc Genocea Biosciences Inc Third Quarter Earnings Conference Call in 2019
11/01/2019 Earnings Genocea Biosciences Inc Third Quarter Earnings in 2019 Release
07/25/2019 08:30 EDT Misc Genocea Biosciences Inc Second Quarter Earnings Conference Call in 2019
07/25/2019 Earnings Genocea Biosciences Inc Second Quarter Earnings in 2019 Release
05/22/2019 Splits Ratio: 1:8
05/15/2019 09:00 EDT Misc Genocea Biosciences Inc Annual General Meeting in 2018
04/30/2019 09:00 EDT Misc Genocea Biosciences Inc First Quarter Earnings Conference Call in 2019
04/30/2019 Earnings Genocea Biosciences Inc First Quarter Earnings in 2019 Release
02/28/2019 09:00 EST Misc Genocea Biosciences Inc Fourth Quarter Earnings Conference Call in 2018
02/28/2019 Earnings Genocea Biosciences Inc Fourth Quarter Earnings in 2018 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.genocea.com
  • Investor Relations URL: http://ir.genocea.com/index.cfm
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Nov. 01, 2019
  • Last Earnings Release: Jul. 25, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Genocea Biosciences Inc is a US-based biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies to address diseases with significant unmet needs. Its product candidate includes GEN-003 which is an immunotherapy for the treatment of genital herpes as well as it owns pre-clinical immuno-oncology program focused on personalized cancer vaccines. The company focuses on developing vaccines and immunotherapies for unmet needs through its AnTigen Lead Acquisition System, which is used to design vaccines and immunotherapies. Genocea operates its business through the single segment being Developing and Commercializing vaccines.

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("GNCA","name")
  • Description: =YCI("GNCA","description")
  • Sector: =YCI("GNCA","sector")
  • Industry: =YCI("GNCA","industry")
  • Est. Current Fiscal Year End: =YCI("GNCA","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.